Sanctuary Advisors LLC acquired a new stake in shares of CME Group Inc. (NASDAQ:CME – Free Report) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 57,177 shares of the financial services provider’s stock, valued at approximately $12,626,000.
A number of other hedge funds have also bought and sold shares of the company. Mizuho Bank Ltd. purchased a new position in shares of CME Group during the 2nd quarter worth about $22,638,940,000. Saranac Partners Ltd purchased a new stake in CME Group in the 2nd quarter worth about $351,000. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in CME Group in the 2nd quarter worth about $17,001,000. Meiji Yasuda Asset Management Co Ltd. bought a new stake in CME Group in the second quarter worth about $658,000. Finally, Magellan Asset Management Ltd bought a new stake in CME Group in the second quarter worth about $8,170,000. Institutional investors own 87.75% of the company’s stock.
Insider Transactions at CME Group
In other CME Group news, Director William R. Shepard acquired 325 shares of the stock in a transaction dated Thursday, June 25th. The stock was purchased at an average price of $230.57 per share, with a total value of $74,935.25. Following the transaction, the director directly owned 260,442 shares of the company’s stock, valued at $60,050,111.94. This trade represents a 0.12% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.30% of the company’s stock.
Analyst Ratings Changes
View Our Latest Stock Analysis on CME
CME Group Price Performance
Shares of CME stock opened at $274.98 on Monday. CME Group Inc. has a twelve month low of $218.31 and a twelve month high of $329.16. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The stock has a fifty day simple moving average of $251.17 and a two-hundred day simple moving average of $279.57. The stock has a market capitalization of $98.88 billion, a price-to-earnings ratio of 23.32, a P/E/G ratio of 3.27 and a beta of 0.23.
CME Group (NASDAQ:CME – Get Free Report) last announced its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, beating the consensus estimate of $2.91 by $0.08. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The firm had revenue of $1.71 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same quarter last year, the firm posted $2.96 earnings per share. The business’s revenue for the quarter was up .8% on a year-over-year basis. On average, analysts predict that CME Group Inc. will post 12.27 EPS for the current fiscal year.
CME Group Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th will be paid a $1.30 dividend. This represents a $5.20 annualized dividend and a yield of 1.9%. The ex-dividend date is Wednesday, September 9th. CME Group’s dividend payout ratio (DPR) is 44.11%.
CME Group Profile
CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
See Also
- Five stocks we like better than CME Group
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
